当前位置: 首页 > 期刊 > 《青岛大学医学院学报》 > 20194
编号:13539804
S100β、IL-1β与IL-6联合检测对青壮年颅脑损伤诊断及预后评估的价值(5)
http://www.100md.com 2019年8月1日 《青岛大学学报(医学版)》 20194
     [21] MICHETTI F, D’AMBROSI N, TOESCA A, et al. The S100B story:from biomarker to active factor in neural injury[J]. Journal of Neurochemistry, 2019,148(2):168-187.

    [22] WELCH R D, AYAZ S I, LEWIS L M, et al. Ability of se-rum glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and S100B to differentiate normal and abnormal head computed tomography findings in patients with suspected mild or moderate traumatic brain injury[J]. Journal of Neurotrauma, 2016,33(2):203-214.

    [23] HELMY A, GUILFOYLE M R, CARPENTER K L, et al. Recombinant human interleukin-1 receptor antagonist promotes M1 microglia biased cytokines and chemokines following human traumatic brain injury[J]. Journal of Cerebral Blood Flow and Metabolism, 2016,36(8):1434-1448.

    [24] WEBSTER K M, SUN M J, CRACK P, et al. Inflammation in epileptogenesis after traumatic brain injury[J]. Journal of Neuroinflammation, 2017,14(1):10-12.

    [25] HELMY A, CARPENTER K L, MENON D K, et al. The cytokine response to human traumatic brain injury:temporal profiles and evidence for cerebral parenchymal production[J]. Journal of Cerebral Blood Flow and Metabolism, 2011,31(2):658-670.

    (本文編辑 马伟平), 百拇医药(张鹏 徐志明 左安俊 刘维生 赵鹏 丁婷)
上一页1 2 3 4 5